Completed |
: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis
: Noninvasive Mucinous Cystadenocarcinoma of Ovary
: 2014-04-22
: Other: A sampling of blood A sampling of blood de 14 ml
|
Terminated |
: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm
: - Mucinous Cystic Tumor With Moderate Dysplasia
- Mucinous Cystadenoma of Pancreas
: 2012-02-01
: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr
|
Active, not recruiting |
: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
: - Borderline Ovarian Mucinous Tumor
- Ovarian Mucinous Cystadenocarcinoma<
: 2010-03-04
: - Biological: Bevacizumab Given
|
Recruiting |
: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
: - Acinar Cell Carcinoma
- Adrenal Cortex Carcinoma
- Adrenal Gla
: 2016-07-13
: - Procedure: Biospecimen Collection
|
Terminated |
: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Clear Cell Cystadenocarcinoma
: 2000-01-28
: - Drug: Carboplatin Given IV
|
Recruiting |
: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
: - Ovarian Brenner Tumor
- Ovarian Carcinosarcoma
- Ovarian Clear
: 2014-03-28
: - Drug: Gemcitabine Hydrochloride
|
Completed |
: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
-
- Drug: TLR8 Agonist VTX-2337 Gi
|
Suspended |
: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
: - Nausea and Vomiting
- Ovarian Brenner Tumor
- Ovarian Clear Ce
: 2011-01-11
: - Procedure: Adjuvant Therapy An
|
Terminated |
: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
: - Adenocarcinoma of the Pancreas
- Adenocarcinoma of the Stomach
-
- Drug: veliparib Given PO
|
Active, not recruiting |
: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
-
- Biological: Bevacizumab Given
|